HK1224181A1 - 抑制 氧化酶活性的組合物 - Google Patents
抑制 氧化酶活性的組合物Info
- Publication number
- HK1224181A1 HK1224181A1 HK16112404.7A HK16112404A HK1224181A1 HK 1224181 A1 HK1224181 A1 HK 1224181A1 HK 16112404 A HK16112404 A HK 16112404A HK 1224181 A1 HK1224181 A1 HK 1224181A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- nadph
- composition
- inhibiting
- oxidase activity
- nadph oxidase
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US85855906P | 2006-11-13 | 2006-11-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1224181A1 true HK1224181A1 (zh) | 2017-08-18 |
Family
ID=39430013
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK16112404.7A HK1224181A1 (zh) | 2006-11-13 | 2016-10-27 | 抑制 氧化酶活性的組合物 |
Country Status (8)
Country | Link |
---|---|
US (1) | US8709434B2 (zh) |
EP (3) | EP2091530B1 (zh) |
CN (2) | CN105520938A (zh) |
CA (1) | CA2668757C (zh) |
ES (1) | ES2608659T3 (zh) |
HK (1) | HK1224181A1 (zh) |
PL (1) | PL2091530T3 (zh) |
WO (1) | WO2008063514A1 (zh) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2166010A1 (en) * | 2008-09-23 | 2010-03-24 | Genkyo Tex Sa | Pyrazolo pyridine derivatives as NADPH oxidase inhibitors |
US8962570B2 (en) | 2011-05-17 | 2015-02-24 | University of Pittsburgh—of the Commonwealth System of Higher Education | Therapeutic use of peptide inhibitors of NADPH oxidase; aerosolization as a delivery mechanism |
CU23963B1 (es) * | 2011-07-01 | 2013-12-11 | Ct De Ingeniería Genética Y Biotecnología | Composiciones farmacéuticas a partir de derivados de la c-ficocianina y combinaciones con interferones del tipo i para el tratamiento de enfermedades cerebrales isquémicas y neurodegenerativas |
WO2013136277A1 (en) | 2012-03-13 | 2013-09-19 | Unimark Remedies Ltd. | Pharmaceutical compositions for treatment of cardiovascular diseases |
CN103585265A (zh) * | 2013-11-27 | 2014-02-19 | 张俊 | 治疗帕金森综合症的药酒 |
CN105998048A (zh) * | 2016-05-13 | 2016-10-12 | 重庆纳德福实业集团股份有限公司 | 一种治疗缺血性脑中风的药物组合物及其制备方法与用途 |
AU2017362328B2 (en) * | 2016-11-15 | 2022-03-31 | Vanderbilt University | Use of 2-hydroxybenzylamine in the treatment and prevention of pulmonary hypertension |
CN112611819B (zh) * | 2020-12-30 | 2022-09-06 | 上海日馨医药科技股份有限公司 | 一种苯磷硫胺原料及其制剂中有关物质的测定方法 |
CN113293190B (zh) * | 2021-07-27 | 2021-10-29 | 中国科学院烟台海岸带研究所 | 藻胆素结合肽及其应用 |
WO2023049479A1 (en) * | 2021-09-24 | 2023-03-30 | Jds Therapeutics, Llc | Compositions and uses of oligo-chromopeptides and methods of making |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5865216A (ja) | 1981-09-16 | 1983-04-18 | Dainippon Ink & Chem Inc | 抗腫瘍剤 |
JPS6013709A (ja) | 1983-07-01 | 1985-01-24 | Nippon Carbide Ind Co Ltd | 新規な化粧品添加物 |
US5047395A (en) * | 1990-07-17 | 1991-09-10 | Nagase Co., Ltd. | Reduction of oxyradical damage in biomedical applications |
US6887260B1 (en) * | 1998-11-30 | 2005-05-03 | Light Bioscience, Llc | Method and apparatus for acne treatment |
US20030032634A1 (en) * | 2001-06-01 | 2003-02-13 | Piganelli Jon D. | Oxidant scavengers for treatment of diabetes or use in transplantation or induction of immune tolerance |
AU2002249795A1 (en) | 2000-11-10 | 2002-07-24 | The President And Fellows Of Harvard College | Compounds and methods for regulating cell differentiation |
WO2004013311A2 (en) * | 2002-08-06 | 2004-02-12 | Diadexus, Inc. | Compositions and methods relating to ovarian specific genes and proteins |
US7795397B2 (en) * | 2004-05-06 | 2010-09-14 | The Regents Of The University Of California | Red and near infrared flourescent phyotochrome |
US20060083727A1 (en) * | 2004-07-15 | 2006-04-20 | Nanobac Pharmaceuticals, Inc. | Methods and compositions for the treatment of diseases characterized by calcification and/or plaque formation |
WO2008000431A2 (en) * | 2006-06-27 | 2008-01-03 | Nutratec S.R.L. | Extracts of aphanizomenon flos aquae and nutritional, cosmetic and pharmaceutical compositions containing the same |
-
2007
- 2007-11-13 WO PCT/US2007/023887 patent/WO2008063514A1/en active Application Filing
- 2007-11-13 EP EP07862004.4A patent/EP2091530B1/en active Active
- 2007-11-13 ES ES07862004.4T patent/ES2608659T3/es active Active
- 2007-11-13 CN CN201510492944.XA patent/CN105520938A/zh active Pending
- 2007-11-13 EP EP16183435.3A patent/EP3111933B1/en not_active Not-in-force
- 2007-11-13 CA CA2668757A patent/CA2668757C/en active Active
- 2007-11-13 EP EP19194976.7A patent/EP3597188A1/en not_active Withdrawn
- 2007-11-13 PL PL07862004T patent/PL2091530T3/pl unknown
- 2007-11-13 US US12/514,578 patent/US8709434B2/en active Active
- 2007-11-13 CN CN200780045897A patent/CN101677992A/zh active Pending
-
2016
- 2016-10-27 HK HK16112404.7A patent/HK1224181A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
CA2668757A1 (en) | 2008-05-29 |
CN101677992A (zh) | 2010-03-24 |
EP3111933A1 (en) | 2017-01-04 |
WO2008063514A1 (en) | 2008-05-29 |
EP2091530A4 (en) | 2010-08-04 |
EP2091530B1 (en) | 2016-09-21 |
US8709434B2 (en) | 2014-04-29 |
CN105520938A (zh) | 2016-04-27 |
US20100172971A1 (en) | 2010-07-08 |
EP3111933B1 (en) | 2019-09-04 |
EP2091530A1 (en) | 2009-08-26 |
ES2608659T3 (es) | 2017-04-12 |
EP3597188A1 (en) | 2020-01-22 |
CA2668757C (en) | 2016-08-23 |
PL2091530T3 (pl) | 2018-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1224181A1 (zh) | 抑制 氧化酶活性的組合物 | |
HK1220208A1 (zh) | 用於酶抑制的化合物 | |
GB0619753D0 (en) | Enzyme inhibitors | |
EP2083074A4 (en) | MODIFIED FLAVIN-ADENINE-DINUCLEOTIDE-DEPENDENT GLUCOSE-DEHYDROGENASE | |
HK1179871A1 (zh) | 作為 氧化酶抑制劑的吡唑並吡啶衍生物 | |
ZA201000318B (en) | Inhibitors of 11b-hydroxysteroid dehydrogenase | |
EP1978975A4 (en) | COMPOSITION FOR INHIBITING ADHESION | |
HK1112463A1 (en) | Imidazo- and triazolopyridines as inhibitors of 11-beta hydroxysteroid dehydrogenase type i | |
IL194339A0 (en) | Enzyme inhibitors | |
IL197714A0 (en) | 2-pyridinecarboxamide derivative having gk-activating activity | |
EP1991200A4 (en) | FLUORCHINOLONZUSAMMENSETZUNGEN | |
WO2009003090A9 (en) | Compositions and methods for inhibiting viral and bacterial activity | |
GB0608821D0 (en) | DHFR enzyme inhibitors | |
EP1969372A4 (en) | METHOD AND COMPOSITIONS FOR DETECTING ENZYMATIC ACTIVITY | |
GB0608844D0 (en) | Enzyme inhibitors | |
EP1923402A4 (en) | PROCESS FOR DETERMINING ENZYME ACTIVITY | |
EP2034019A4 (en) | COMPOSITION FOR THE NUCLEENIC ACID INTRODUCTION | |
GB0617161D0 (en) | Enzyme inhibitors | |
ZA200805723B (en) | Enzyme and photobleach containing compositions | |
GB0708221D0 (en) | Corrosion-inhibiting composition | |
ZA200808237B (en) | Enzyme inhibitors | |
GB0612544D0 (en) | Enzyme inhibitors | |
GB0624958D0 (en) | Enzyme inhibitors | |
GB0620884D0 (en) | Enzyme inhibitors | |
GB0600862D0 (en) | Enzyme |